Aclacinomycin methylesterase (RdmC) is one of the tailoring enzymes that modify the aklavinone skeleton in the biosynthesis of anthracyclines in Streptomyces species.
Anthracyclines are aromatic polyketide antibiotics, which are synthesized by Streptomyces species. They were recognized as early as 1939 for their antibacterial properties (1) and are used as important anti-tumor drugs in chemotherapy since more than three decades (2) . Their mode of action is not yet fully understood, but there is evidence that their cytotoxic activity is at least in part due to inhibition of topoisomerase II (3) . However, anthracyclines exhibit severe cardiotoxic side effects, which limit their long-term use in the clinic (4) . Due to their complex composition and structure, these compounds are difficult to synthesize chemically. The search for novel derivatives with less toxic side effects has therefore so far been limited to the hybrid antibiotic approach which rests on gene transfer of a particular set of genes from one Streptomyces species to another, resulting in production of novel anthracycline metabolites (5) (6) . Alternative routes to non-natural anthracyclines could be based on knowledge of the 3D-structures of the enzymes involved in the biosynthesis of these metabolites. Mechanistic and structural information can be fed into the re-design of these enzymes, which may be used for the biosynthesis of anthracyclines with improved or novel toxicological avtivities.
Most anthracyclines consist of a 7,8,9,10-tetrahydrotetracene-5,12-quinone skeleton, which is glycosylated at position C-7 or C-10 (figure 1a). Variations in the modifications of the aglycone skeleton or the type of carbohydrate attached lead to considerable chemical diversity, and several hundreds of these natural products are known to date (7) . Biosynthesis starts with the polyketide pathway, where the carbon chain is built up by repeated Claisen condensations from acyl and malonate carbonyl units by the large polyketide synthase complex (8) . These condensation steps are followed by a final cyclization to give the aglycone polyketide skeleton (9). The cyclized product is then further modified by a series of tailoring enzymes, leading to for example glycosylation, hydroxylation, methylester hydrolysis and decarboxylation (10) (11) (12) (13) (14) (15) .
In S. purpurascens, the rdm operon contains several genes which code for tailoring enzymes of rhodomycin biosynthesis (5, 16) . Enzymes encoded by this gene cluster include RdmA, an aklanonic acid methylester cyclase, and aklavinone-11-hydroxylase by guest on http://www.jbc.org/ Downloaded from RdmE, which converts aklavinone to e-rhodomycinone (11) . Genetic evidence suggests that rdmB and rdmC code for two enzymes, which catalyze the steps leading from e-rhodomycinone glycoside to b-rhodomycinone glycoside (16) . Both in vivo and in vitro experiments have shown that these two enzymes can also catalyze the conversion of aclacinomycin to 10-hydroxy-10-decarboxymethylaklavin (14) .
Aclacinomycin methyl esterase (RdmC) (14) catalyzes removal of the methoxygroup at the C-15 position of aclacinomycin T and aclacinomycin A (figure 1). The polypeptide chain contains 298 amino acids, and the enzyme is monomeric in solution (14) . RdmC shows about 50 % sequence identity to related enzymes from other Streptomyces species, for instance DnrP from S. peucetius and DauP from S. sp strain C5 (17, 18) . These enzymes catalyze similar reactions, hydrolysing 10-carbomethoxy-13-deoxycarminomycin to 10-carboxy-13-deoxycarminomycin (12, 17) . They all contain the same sequence motif G-X-S-X-G, typical for a serine hydrolase active site (18) .
Here we report the crystal structures of RdmC with the bound product analogues 10-decarboxymethylaclacinomycin T (DcmaT) and 10-decarboxymethylaclacinomycin A (DcmaA) at molecular resolution. The enzyme contains the a/b hydrolase fold, with a catalytic triad common to this enzyme family. Modelling of the substrate complex based on these structures suggests that the catalytic serine residue is perfectly located to act as nucleophile during hydrolysis, and that the negative charge developing in the transition state and the tetrahedral intermediate could be stabilized by an oxyanion hole consisting of the main chain nitrogens of residues Gly32 and Met103.
buffer, containing 1 mM DTT. The complex was crystallized by vapour diffusion in hanging drops with ammonium sulphate as precipitant at pH 7.5. Details of the crystallization protocol is described elsewhere (19) . An isomorphous platinum derivative was obtained by soaking the native crystals for 45 minutes in 5 mM K 2 PtNO 3 dissolved in water.
X-ray data collection and processing: Native diffraction data for the AcmT and AcmA complexes were collected at the European Molecular Biology Laboratory Refinement: Initial refinement was performed with CNS (27) . 8 % of the reflections were set aside for cross-validation by the use of R free (28) . The first steps consisted of rigid body refinement and simulated annealing procedures. Subsequent rounds of refinement included energy minimization and B-factor refinement, followed by manual adjustment of the model using O (26) . The bound ligand could be fitted straightforwardly into the electron density map, and water molecules were identified by guest on http://www.jbc.org/ Downloaded from using PEAKMAX and WATPEAK (22) . The final cycles of refinement using REFMAC (29) resulted in a well defined model with R work of 16.3 % and R free of 18.7 % (table 3) . Individual, isotropic B-factors were used thoughout the refinement, because anisotropic B-factors did not lead to a decrease in R free .
The RdmC-AcmA complex crystallized isomorphously to the RdmC-AcmT complex and the refined coordinates of the RdmC-AcmT complex were used for the calculation of initial 2F o -F c and F o -F c difference electron density maps, without contributions of bound AcmT in the structure factor calculation. Refinement of the RdmC-AcmA complex followed the protocol outlined above, except that REFMAC (29) 
Results and discussion
Quality of the electron density map and the model: RdmC was crystallized as a complex with AcmA or AcmT and the 3D structures of these complexes were determined to 1.45 Å and 1.95 Å, respectively, using single isomorphous replacement, including anomalous scattering based on a platinum derivative, as described in experimental procedures. The electron density is well defined for all 298 amino acid residues except for the N-terminal methionine which is removed by the cloning host (11) and one loop, comprising residues 166-169, where the side chains are not visible.
This presumably reflects disorder of this loop, which is at the surface of the enzyme. 7 The enzyme was crystallized in the presence of substrate and the electron density maps clearly show a bound ligand in the active site (figure 2). However, there is no electron density for the carboxymethyl group at position C-10 of the product. The loss of the C-15 methyl group was expected, since the enzyme is active at the pH of crystallisation. The product of the RdmC reaction, 15-demethoxyaclacinomycin, is however unstable in water and slowly undergoes decarboxylation in solution (35) .
The electron density is consistent with the bound product analogues 10-decarboxymethyl aclacinomycin, DcmaA or DcmaT, respectively and thus suggests that decarboxylation has occurred during the crystallization process.
The final models of the protein consist of 297 amino acids, 406 water molecules, one sulphate ion, one PEG400 molecule and a DcmaA or DcmaT molecule. They also contain three residues with double conformations and Pro254 in cis conformation. 
Active site and substrate binding
The active site and substrate binding pocket of RdmC is located at the interface between the two domains. Residues from helices D´1, D´2, D´5, b6 and aC form the predominantly hydrophobic substrate binding pocket and the catalytic triad is located at the end of this deep pocket (figure 3a). Ser102 is located in a strand-turn-helix motif, at the so called nucleophilic elbow and is a central residue in the very sharp turn between strand five and helix C. The nucleophilic elbow is the most conserved structure within the a/b hydrolase fold and includes the conserved motif G-X-S-X-G (40). Asp248 is found in a loop between strand seven and helix E (in some enzymes of the a/b hydrolase family, it could also be found after strand six (36) ) and His276 is located between strand eight and helix F. In the RdmC-DcmaA complex, the density for the aglycone and the first carbohydrate moiety is well defined in the electron density map. This part of DcmaA binds to RdmC in a manner indistinguishable from that of DcmaT. The additional carbohydrate moieties of DcmaA are extending out of the binding pocket into the bulk solution (figure 4a) and form only one interaction with an enzyme residue, a hydrogen bond between the oxygen atom O12 of the second sugar unit and the main chain oxygen atom of Tyr220. As a result, these two carbohydrate units are less well defined in the electron density map. This mode of binding on the other hand explains why both compounds are recognized as substrates by RdmC and why there is only modest discrimination between the mono-and triglycosylated anthracyclines (43) .
Polyethylene glycol binding
Strong difference density was found in a hydrophobic pocket adjacent to the active site. The shape and size of the electron density suggested a bound polyethylene glycol molecule consisting of 10 carbons and 6 oxygens (C 10 H 20 O 6 ) (figure 2). PEG400 had been used in the crystallization liquor and was also used as cryoprotectant.
The electron density suggests, that a fraction of the bound polyethylene glycole molecules is covalently attached via the terminal aldehyde group to the catalytic Ser102, thereby mimicking the covalent acyl-enzym complex. Refinement of such a model however shows that the fraction of the covalently linked PEG molecules is rather small. The polyethylene molecule forms hydrogen bonds to the side chain oxygens of Tyr198 and Glu202 and two water molecules. The PEG binding pocket is accessible from the outside solution via a small opening (figure 4a) lined mostly by hydrophobic residues such as Val212, Pro216, Gly63, Ala209, Thr62, Leu213 and Ile206. A similar pocket is found both in chloroperoxidase and bromoxidase but in these enzymes the pocket is smaller in size. It has been suggested that this pocket may be used for transport of reactants/products such as peroxides, halides and water molecules in bromoperoxidase (38) , and may be utilized in a similar manner in RdmC.
Mechanistic implications
RdmC is an esterase that removes the methoxy side chain at carbon 15 of AcmA or AcmT. In the structures of both complexes, obtained at pH 7.5, we observe the demethylated and decarboxylated product analogues, DcmaA and DcmaT, respectively. These structures allow the modelling of the AcmT substrate into the active site pocket, thus providing a picture of the enzyme-substrate interactions before the reaction takes place ( figure 5 ). In this model, the side chain of the nucleophile, 
RdmC is a representative of a class of esterases in anthracycline biosynthesis
The highest sequence similarity of RdmC is to esterases from other Streptomyces species. DnrP from Streptomyces peucetius and DauP from Streptomyces sp. C5
exhibit sequence identities to RdmC of 51% and 53%, respectively (12, 17) . DnrP and 
Values in parenthesis are for the highest resolution shell. 1) R sym = S hkl S i ½I i -<I>½/S hkl S i <I>, where I i is the intensity measurements for a reflection and <I> is the mean value for this reflection. Table 2 . Phasing statistics 
1) R der = S|F PH -F P | /S|F P | where F PH is the structure factor amplitude of the derivative crystal and F P that of the native. 2) R cullis = S||F PH ± F P | -|F H(calc) | / S|F PH -F P |, where F PH and F P are defined as above and F H(calc) is the calculated heavy atom structure factor amplitude summed over centric reflections.
3) Phasing power = F(H)/E, the r.m.s. heavy atom structure factor amplitude divided by the lack of closure error. 
